Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)

PHASE3CompletedINTERVENTIONAL
Enrollment

929

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2017

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

Inspire Upper Airway Stimulation System

Inspire Upper Airway Stimulation System, is a permanent, implantable therapy device, which consists of three implantable components: IPG, stimulation lead, and a sensing lead. In additional the patient receives a remote to activate the therapy.

Trial Locations (22)

15219

University of Pittsburgh Medical Center; Montefiore, Oakland

29425

Medical University of South Carolina, Charleston

30342

Advanced ENT, Atlanta

33606

University of South Florida, Tampa

33707

Clinical Research Group of St. Petersburg, Inc., St. Petersburg

44106

University Hospitals / Case Western Reserve, Cleveland

45267

University of Cincinnati Medical Center, Cincinnati

48201

Wayne State University / Detroit Medical Center, Detroit

49048

Borgess Research Institute, Portage

53226

Froedtert Memeorial Hospital, Milwaukee

55422

North Memorial Medical Center, Maple Grove

56303

St. Cloud ENT, Saint Cloud

75231

Sleep Medicine Associates of Texas, Dallas

94303

California Sleep Institute, Palo Alto

98122

Swedish Health Services, Seattle

Unknown

Deparment of Pulmonology Head and Neck Surgery, Universitair Ziekenhuis Antwerpen, Antwerp

Central Hospital University of Bordeaux, Bordeaux

Hospital Foch, Paris

Krankenhaus Bethanien Solingen, Solingen

St. Franziskus Hospital, Cologne

Universitäts-HNO-Klinik Mannheim, Mannheim

St. Lucas Andreas Ziekenhuis, Amsterdam

Sponsors
All Listed Sponsors
lead

Inspire Medical Systems, Inc.

INDUSTRY

NCT01161420 - Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com) | Biotech Hunter | Biotech Hunter